SCHEDULE 13D/A: Activist Shareholders Escalate Proxy Fight at Lifeway Foods, Citing Poor Q1 Performance and Governance Failures

Sentiment:

Shareholder Activism Update


Edward and Ludmila Smolyansky, significant shareholders of Lifeway Foods, have filed a revised preliminary consent statement to remove and replace the company's board of directors, citing concerns over declining operational performance and governance issues.

Worse than expectedIncome from operations declined nearly 55% year-over-year in Q1 2025.Operating margin fell to approximately 3.4% in Q1 2025, down from 7.9% in Q1 2024.Net sales declined 1.8% sequentially from Q4 2024.Gross margin contracted by 180 basis points to 24.0%.Selling expenses rose sharply (up 27% year-over-year and 35% from Q4) without a corresponding increase in sales.SG&A expenses climbed to 20.2% of sales.Revenue from the 2021 acquisition of Glen Oaks has declined approximately 50% to date.

Summary

  • Edward and Ludmila Smolyansky, beneficial owners of approximately 27% of Lifeway Foods, have filed an Amendment No. 23 to Schedule 13D and a revised preliminary consent statement.
  • They are seeking shareholder consent to repeal any bylaw amendments made by the Board since March 24, 2023, remove current directors, and elect a new slate of seven directors including themselves.
  • They also propose amending the bylaws to prohibit the company from employing immediate family members of the President or Chief Executive Officer.
  • Their actions are driven by "serious concerns" about Lifeway's Q1 2025 performance and the Board's "ongoing pattern of poor governance and misaligned priorities."
  • They criticize the 2021 acquisition of Glen Oaks, whose revenue has declined approximately 50% to date, noting that only Edward and Ludmila Smolyansky voted against it.
  • Concerns were also raised regarding insider stock sales by Director Pol Sikar and CEO Julie Smolyansky following the Q1 2025 earnings release.
  • The Smolyanskys advocate for a reconstituted Board with an independent committee tasked with assessing strategic alternatives, including potentially re-engaging with Danone.

Sentiment

Score: 3

Explanation: The document expresses strong negative sentiment from significant shareholders regarding the company's financial performance, operational efficiency, and corporate governance. It details multiple declining financial metrics and criticizes management decisions, indicating a highly critical and adversarial stance.

Positives

  • Lifeway Foods reported a 44% year-over-year increase in GAAP earnings per share for Q1 2025, though this was attributed by the Smolyanskys solely to a one-time $3.4 million gain from an investment sale.

Negatives

  • Income from operations declined nearly 55% year-over-year in Q1 2025.
  • Operating margin fell to approximately 3.4% in Q1 2025, down from 7.9% in Q1 2024.
  • Net sales increased only 3.3% year-over-year in Q1 2025, and declined 1.8% sequentially from Q4 2024.
  • Revenue from the 2021 acquisition of Glen Oaks has declined approximately 50% to date.
  • Selling expenses rose sharply, up 27% year-over-year and 35% from Q4, without a corresponding increase in sales.
  • Gross margin contracted by 180 basis points to 24.0%; SG&A expenses climbed to 20.2% of sales.
  • Insider stock sales by Director Pol Sikar and CEO Julie Smolyansky occurred following the May 15, 2025 earnings release.
  • Questionable compensation awards of $8.5 million in cash and shares were granted to CEO/Chair Julie Smolyansky at the end of 2024, which were viewed as being in "flagrant opposition to shareholder sentiment."
  • The combined CEO/Chair role, while occupied by Ms. Smolyansky, is considered a "significant governance failure resulting in lack of independent oversight."
  • The handling of Danone's offer and subsequent attempt to sever ties may have market implications that the Board has failed to consider.

Risks

  • Potential market implications from the Board's handling of Danone's offer and attempt to sever ties.
  • Risk of continued decline in operational performance if current trends persist, including declining income from operations, contracting margins, and rising expenses without corresponding sales growth.
  • Risk of value destruction due to alleged poor governance and misaligned priorities.
  • Risk of invalidly issued and outstanding shares, specifically those purported to have been issued to Julie Smolyansky or her spouse without Danone North America PBC's consent.

Future Outlook

The document primarily focuses on past performance and proposed governance changes rather than explicit forward-looking statements or company guidance. Edward Smolyansky expresses confidence in "broad support for swift and decisive change" from the investment community. The Smolyanskys' stated aim is to restore operational discipline, shareholder alignment, and long-term value creation for Lifeway Foods.

Management Comments

  • "After carefully considering our options, we have determined that this consent path offers the quickest and most efficient route to achieving our goals and objectives." Edward Smolyansky
  • "I feel confident, based on outreach I have received from the investment community, that there is broad support for swift and decisive change." Edward Smolyansky

Industry Context

The document highlights a shareholder activism campaign within the consumer packaged goods (CPG) industry, specifically targeting a food and beverage company. It touches upon common themes in such campaigns: concerns over declining operational metrics, executive compensation, M&A effectiveness (Glen Oaks acquisition), and corporate governance structures (combined CEO/Chair role, board independence). The mention of Danone, a major global food corporation, suggests a potential strategic partnership or acquisition opportunity that the current board allegedly mishandled, which is a significant factor in the CPG M&A landscape.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorEach current director of the Company and any other director appointed by the Board on or after June 15, 2024Ludmila Smolyansky, Edward Smolyansky, Richard Beleutz, Cindy Curry, Michael Leydervuder, George Sent, Robert WhalenUpon approval of the consent solicitation proposalsTo address concerns over poor governance, misaligned priorities, and declining operational performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Repeal of Bylaw AmendmentsTo repeal any amendment to the Second Amended and Restated By-Laws made by the Board that became effective on or after March 24, 2023, and prior to the effective date of this proposal.Upon proposal becoming effectiveAims to reverse recent governance changes made by the current board, potentially restoring previous corporate governance structures.
Bylaw AmendmentTo amend the Bylaws to prohibit the Company from employing or engaging any immediate family member of the Company's president or chief executive officer.Upon proposal becoming effectiveAims to enhance corporate governance by preventing potential conflicts of interest and promoting independent management.
Board Structure/OversightCriticism of the combined CEO/Chair role, while occupied by Ms. Smolyansky, as a significant governance failure resulting in lack of independent oversight.OngoingHighlights a perceived lack of checks and balances, potentially leading to less effective strategic decision-making and accountability.

Related Party Transactions

  • Shares purported to have been issued to Julie Smolyansky or her spouse without the consent of Danone North America PBC, which the filing persons do not concede are validly issued and outstanding.
  • Award of $8.5 million in cash and shares granted to CEO/Chair Julie Smolyansky by the Board at the end of 2024, which the Smolyanskys view as "questionable" and "in flagrant opposition to shareholder sentiment."

Stakeholder Impact

  • Shareholders: Potential for significant changes in company direction and governance, aiming to restore long-term value. Current shareholders may experience volatility due to the ongoing proxy fight.
  • Management/Board: Current management and board members face potential removal and scrutiny over past decisions and compensation.
  • Employees: Potential for changes in company strategy and operations under new leadership, including a proposed bylaw prohibiting employment of immediate family members of the CEO/President.
  • Danone North America PBC: The Smolyanskys propose re-engaging with Danone, suggesting a potential shift in the relationship or strategic partnership.

Next Steps

  • Edward and Ludmila Smolyansky will continue their consent solicitation campaign.
  • They intend to mail a definitive proxy statement or definitive consent statement and accompanying cards to requisite shareholders.
  • The Smolyanskys are calling for immediate action to restore operational discipline, shareholder alignment, and long-term value creation.
  • A reconstituted Board with an independent committee is proposed to assess strategic alternatives and potentially re-engage with Danone.

Key Dates

DateDescription
1999Year of the Company's Stockholder Agreement with Danone.
2021Year of the acquisition of Glen Oaks.
March 24, 2023Date after which any bylaw amendments made by the Board are proposed to be repealed.
June 15, 2024Date after which any directors appointed by the Board are proposed to be removed.
August 2024Preliminary consent statement submitted by the Smolyanskys.
December 2024Questionable compensation awards granted to CEO/Chair Julie Smolyansky.
March 13, 2025Date of event which requires filing of this statement (Amendment No. 23).
March 28, 2025Smolyanskys filed a preliminary proxy statement.
March 31, 2025End of period for Company's Quarterly Report on Form 10-Q.
April 10, 2025Sale of 10,000 shares by Ludmila Smolyansky Trust 2/1/05 at $23.51.
April 11, 2025Sale of 15,000 shares by Ludmila Smolyansky Trust 2/1/05 at $23.38.
April 14, 2025Sale of 8,376 shares by Ludmila Smolyansky Trust 2/1/05 at $23.62.
April 15, 2025Sale of 8,676 shares by Ludmila Smolyansky Trust 2/1/05 at $23.88.
April 16, 2025Edward Smolyansky filed a preliminary proxy statement with the SEC.
April 17, 2025Sale of 17,948 shares by Ludmila Smolyansky Trust 2/1/05 at $23.92.
April 29, 2025Sale of 9,561 shares by Ludmila Smolyansky Trust 2/1/05 at $23.73.
April 30, 2025Sale of 10,957 shares by Ludmila Smolyansky Trust 2/1/05 at $23.81.
May 1, 2025Sale of 30,000 shares by Ludmila Smolyansky Trust 2/1/05 at $23.87.
May 5, 2025Amended preliminary proxy statement filed by the Smolyanskys.
May 5, 2025Sale of 7,482 shares by Ludmila Smolyansky Trust 2/1/05 at $23.50.
May 6, 2025Date as of which 15,203,241 shares were reported outstanding.
May 13, 2025Company's Quarterly Report on Form 10-Q for period ended March 31, 2025, filed with SEC.
May 15, 2025Q1 2025 earnings release date.
June 2, 2025Edward Smolyansky and Ludmila Smolyansky filed a revised preliminary consent statement and Mr. Smolyansky issued a press release.
June 4, 2025Date of filing of this Schedule 13D Amendment No. 23.

Recommendation

sell

Keywords

Lifeway Foods, LWAY, SEC filing, Schedule 13D, Edward Smolyansky, Ludmila Smolyansky, consent solicitation, proxy fight, corporate governance, shareholder activism, board removal, director election, financial performance, Q1 2025, Danone, Glen Oaks acquisition, insider trading, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.